Arisan Therapeutics Inc - CA San Diego, San Diego 92121

Arisan Therapeutics Inc entered the industry of Biological Research in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 541712, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.

To acquire more information, please contact Ken Mccormack by calling (409) 246-4238 during business hours. You can also write to the business’ Single Location at 11189 Sorrento Valley Road # 104, San Diego, California CA 92121. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Arisan Therapeutics Inc
Representative: Ken Mccormack
Place of Business: 11189 Sorrento Valley Road # 104, San Diego, CA 92121
Contact Number: (409) 246-4238
Type of Service: Biological Research
SIC Number: 8731
NAICS Number: 541712
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2010
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Arisan Therapeutics Inc is a company operating from San Diego, California providing professional Biological Research and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 541712 as Biological Research.

With a current employee count of 1 to 4, Arisan Therapeutics Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Ken Mccormack at (409) 246-4238 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 11189 Sorrento Valley Road # 104 in San Diego, California 92121 and can be engaged online through the company website at , the company Twitter , and Facebook page .